Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium (American Journal of Gastroenterology (2018) DOI: 10.1038/s41395-018-0162-0)

Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey, Justin Hartke, Prianka Chilukuri, Jenna Koliani-Pace, Adam Winters, Leah Katta, Eugenia Shmidt, Robert Hirten, David Faleck, Malav P. Parikh, Diana Whitehead, Brigid S. Boland, Siddharth Singh, Sashidhar Varma Sagi, Monika Fischer, Shannon ChangMorris Barocas, Michelle Luo, Karen Lasch, Matthew Bohm, Dana Lukin, Keith Sultan, Arun Swaminath, David Hudesman, Nitin Gupta, Bo Shen, Sunanda Kane, Edward V. Loftus, Corey A. Siegel, Bruce E. Sands, Jean Frederic Colombel, William J. Sandborn, Parambir S. Dulai

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY-NC-ND license. The PDF and HTML versions of the Article have been modified accordingly.

Original languageEnglish (US)
Pages (from-to)696
Number of pages1
JournalAmerican Journal of Gastroenterology
Volume114
Issue number4
DOIs
StatePublished - Apr 1 2019

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium (American Journal of Gastroenterology (2018) DOI: 10.1038/s41395-018-0162-0)'. Together they form a unique fingerprint.

Cite this